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ABSTRACT 
 
Jade A. Bender 
 
Clinical Child Psychology Program 
 
Departments of Applied Behavioral Science and Psychology, October 2007 
 
University of Kansas 
 
Recent adherence theories have diverged to include two subtypes of non-adherence: 
inadvertent (e.g., forgetting) and volitional. Volitional non-adherence focuses on deliberate 
changes that patients and families make to their prescribed medication regimens. The 
purpose of this study was to (a) describe the types of changes parents make to their child’s 
asthma regimen and the motivating factors for those changes, and (b) explore potentially 
related medical and psychological factors. Findings indicated that approximately 80% of 
parents reported making purposeful changes to their child’s asthma regimen and that the 
majority of these changes involved decreasing prescribed medications. Furthermore, the most 
commonly reported reasons for making changes to medications included a desire to reduce 
treatment burden, control symptom exacerbations, and improve quality of life. Lastly, 
findings indicated that parents who were volitionally non-adherent did not differ significantly 
with regard to perceived self-efficacy for asthma management and disease severity when 
compared to parents who reported being adherent. This study highlights the importance of 
considering and incorporating the family’s view and overall treatment goals when 
prescribing treatment regimens. 
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Volitional Non-adherence in Pediatric Asthma: 
Its Occurrence and Relation to Disease Severity and Self-Efficacy 
 With prevalence rates ranging from 5.7% to 11.9%, depending on the state, asthma 
impacts the lives of approximately 6.2 million children in the U.S. (American Lung 
Association (ALA), 2006; Center for Disease Control and Prevention (CDC), n.d.). Asthma 
is defined by wheezing episodes, shortness of breath, chest tightness, and/or coughing. 
Currently, there is no cure for childhood asthma; however, with proper disease control, 
children can live healthy, productive lives. Managing the disease involves avoiding triggers, 
such as allergens and irritants (e.g., smoke), and following a medication regimen. The 
regimen (i.e., asthma action plan) usually involves a combination of inhaled corticosteroids, 
or “controller” medicines that are taken daily to prevent symptoms, and bronchodilators, or 
“rescue” medicines that are taken during a symptom exacerbation (Schaffer, 2006). 
Like other chronic diseases, non-adherence is a prevalent concern with asthma. In 
fact, researchers have found that only about 20-73% of prescribed asthma medication doses 
are taken (Cochrane, Bala, Downs, Mauskopf, & Ben-Joseph, 2000) and that the mean rate of 
non-adherence for asthma medications in children is around 48% of prescribed doses 
(McQuaid, Kopel, Klein, & Fritz, 2003). Negative outcomes associated with non-adherence 
in asthma include overutilization of medical services, sleep disturbance, decreased 
participation in physical activity, and death (Schaffer, 2006). Non-adherence to asthma 
medications is also responsible for 14 million missed days of school annually and is among 
the third ranking cause of hospitalizations of children under the age of 15 (ALA, 2006; CDC, 
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n.d.).  The high rates and significant impact of non-adherence to pediatric asthma regimens 
underscore the importance of understanding its occurrence.  
Generally speaking, adherence, as a concept, has consisted of the assumption that 
patients’ behaviors regarding their medications, diets, and lifestyle changes, should conform 
to medical providers’ recommendations (see Noble, 1998; Trostle, 2000 for a description of 
adherence theories). However, a recent paradigm shift involving a patient-centered 
perspective has led to new ways of thinking about what motivates patients’ medical attitudes 
and behaviors. Bauman (2000) posited that there are, in fact, two types of non-adherence:  
inadvertent and volitional. While inadvertent non-adherence entails not following the 
providers’ recommendations because of an unintentional oversight such as forgetting 
medications or not understanding treatment plans (e.g., Rand, 2005), volitional non-
adherence involves reasoned or purposeful decision-making on the part of the patient not to 
follow the providers’ recommendations (Adams, Dreyer, Dinakar, & Portnoy, 2004; 
Bauman, 2000). Thus, an example of volitional non-adherence would be when parents decide 
to decrease the amount of medication their child is taking each day because they do not like 
the side effects of the medication. 
The concept of volitional non-adherence centers around two basic assumptions.  First, 
it assumes that patients and their families have special expertise about the illness that 
complements the knowledge of medical professionals.  Consequently, this assumption 
implies that the patient and his or her family should be included as an integral part of the 
medical decision-making team (e.g., Bauman, 2000; Korsch & Marcy, 2000). Second, 
volitional non-adherence assumes that part of the decision-making process for patients is 
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determining how to balance the burden of the disease with the burden of treatment. In other 
words, patients and their families may actively change their recommended treatment because 
the cost-benefit ratio for fully participating in treatment favors non-adherence (e.g., Bauman, 
2000; George & Apter, 2001). 
Currently, most of the literature on volitional non-adherence is largely theoretical. For 
instance, Bauman (2000) posited several possible risk factors for volitional non-adherence, 
including difficult medical regimens, patient skepticism about the efficacy of the treatment, 
and family financial concerns. However, only a few studies have examined why families 
intentionally alter their medication regimens and the implications of such medication 
changes. For instance, Deaton (1985) conducted a study on children with asthma and their 
parents and found that patient and family beliefs about compliance were associated with 
better outcomes (e.g., quality of life, illness control), whereas their degree of compliance was 
not. More specifically, parents expressed beliefs about having expertise that supplemented 
the provider’s abilities and reported that changing the medication regimen was a viable 
option. Greaves, Hyland, Halpin, Blake, and Seamark (2005) further supported the idea that 
patients feel they have the right to change their medication regimen by finding that there are 
three self-reported patterns of medication use in adults with asthma. The “regular” pattern 
describes patients who primarily adhere to their treatment regimen. The “regular-but-less” 
pattern refers to patients who take their medications on schedule but in lower doses, and the 
“symptom-directed” pattern pertains to patients who change their medication regimen in 
response to variability in their symptoms. Greaves and colleagues also found that these 
patterns of adherence led to comparable numbers of unscheduled clinic visits and quality of 
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life in patients with mild to moderate asthma, suggesting that volitional non-adherence did 
not result in adverse outcomes.  However, outcomes differed between patterns of adherence 
for patients with severe asthma, perhaps because non-adherence has the potential to lead to 
more serious health concerns. Taken together, findings by Deaton (1985) and Greaves et al. 
(2005) suggest that patients or parents make intentional changes to medications and that, in 
some cases, these changes are not associated with maladaptive outcomes.  
Graves and colleagues (in press) added further insight into these changes by 
describing the types of changes parents of children with asthma make to their medications 
and the motivating factors for these changes. For instance, they noted that families tend to 
decrease their controller medications and increase their rescue medications. This corresponds 
with Modi and Quittner’s (2006) findings that daily medicines, such as controllers, present 
greater numbers of treatment barriers than short term medications, such as rescue inhalers. 
Though volitional non-adherence per se was not assessed in this study, one might infer that 
more barriers could lead to planned decisions not to adhere to a regimen. Examples of 
barriers that Modi and Quittner identified and could potentially motivate volitional non-
adherence include side effects (e.g., taste), time management, and child opposition. 
While this research provides some initial insight into volitional non-adherence with 
pediatric asthma, many questions remain unanswered. For instance, little research has been 
conducted to describe the types of patients and families that are most likely to volitionally 
non-adhere to their medication regimen and elucidate the motivating factors for volitional 
non-adherence. Furthermore, little is understood about what psychological factors might be 
associated with volitional non-adherence (e.g., self-efficacy with regards to managing the 
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medical regimen).  Such investigation should lead to a better understanding of how to 
intervene effectively with non-adherent families to promote optimal health outcomes.  
As a result, this study has three aims. First, a newly developed measure of volitional 
non-adherence in parents of children with asthma will be used to obtain descriptive data with 
regard to the types of volitional changes parents make to their children’s asthma medications 
and the possible reasons why they make these changes. Based on clinical experience and 
existing (but limited) research, it is hypothesized that parents will (a) more likely report 
increasing rescue medications and decreasing controller medications when making volitional 
changes; (b) most often endorse improving quality of life and alleviating symptom 
exacerbations as motivating factors for increasing medications; and (c) most often report a 
desire to reduce treatment burden, evaluate the child’s need for medications, and decrease 
side effects as reasons for decreasing their child’s medications.  
The second aim is exploratory and examines whether parents who engage in 
volitional non-adherence differ significantly from parents who report adhering to their child’s 
prescribed regimen with regard to parents’ perceived self-efficacy in preventing and 
managing their child’s asthma. This variable was chosen because it reflects parents’ 
perception of their ability to identify symptoms accurately and then appropriately respond to 
exacerbations, as well as their perceived ability to manage their child’s asthma and thereby 
prevent symptom flares. It is possible that parents who have a greater understanding of their 
child’s asthma symptoms and are more confident about their abilities to manage the asthma 
will be more likely to alter their child’s medication to meet their treatment goals.  
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Finally, the third aim of this study investigates whether parents who report volitional 
non-adherence endorse significantly more asthma symptoms and functional impairment for 
their child than parents who report adhering to their child’s asthma regimen. Deaton (1985) 
suggested that despite being non-adherent, many families may still effectively manage their 
child’s symptoms by following aspects of the prescribed medication regimen rather than the 
entire regimen. For instance, although controller medications are intended to be taken on a 
daily basis, Boushey, Sorkness, King, and Sullivan (2005) found that intermittent use of 
controller medications produced similar rates of symptom exacerbations as daily use in their 
sample of adult patients. Thus, it is possible that parents who endorse volitional non-
adherence will report similar levels of symptom exacerbations and impairment for their 
children when contrasted with reports of adherent parents, based on the assumption that non-
adherent families are altering their child’s medication regimens in response to their child’s 
treatment needs. 
Method 
Participants 
 Caregivers of children with asthma were recruited from two university-affiliated 
hospitals, one in the Midwest and the other in the southern United States. Caregivers were 
approached at the time of their child’s routine appointment in an asthma clinic if they (a) had 
a child between the ages of 1 and 17 years with an established diagnosis of asthma; and (b) 
could speak English and had the requisite reading skills to complete a series of study-related 
questionnaires.  
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Measures  
 The Asthma Care Behaviors Questionnaire – Parent Version (ACBQ; see Appendix 
A) is a 51 item measure that was designed to assess volitional non-adherence in parents of 
children with asthma. More specifically, the measure queries parents about what types of 
asthma and allergy medications their child has been prescribed and whether or not they have 
intentionally modified the ways in which their child took the medicine over the last three 
months (7 items). The ACBQ also uses a true/false response format to ask parents why they 
increased and/or decreased their child’s medications (38 items), and how they generally went 
about making those changes (6 items).  
 A panel of four asthma, allergy, and psychology professionals devised the ACBQ. Its 
development began with a review of the literature on volitional non-adherence and panel 
discussion of related constructs. Eventually, its content (type of volitional non-adherence, 
motivating factors underlying it, and general approach) was agreed on and three 
corresponding sections were created. For the first section, all classes of current asthma and 
allergy medications were identified and separated by mode of delivery (e.g., nebulizer versus 
metered dose inhaler) because the panel agreed that families might modify one type of 
medication and/or mode of delivery, but not another. For the second section, the panel used 
reviews of adherence barriers literature and clinical experience to generate various reasons 
that could potentially motivate families to increase or decrease medications beyond physician 
instructions. For the final section of the ACBQ, items were generated with regard to overall 
approach to the family’s decision-making process. Finally, questionnaire instructions were 
fine-tuned to be certain that parents were recording responses reflecting volitional non-
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adherence instead of inadvertent non-adherence and/or changes that were stipulated in the 
child’s asthma action plan. 
The panel then solicited input from other asthma and psychology colleagues on the 
structure and content of the first draft of the questionnaire (version 1.0).  After making 
suggested revisions, the ACBQ (version 2.0) was administered to a pilot group of 10 
families, followed by individual, semi-structured interviews designed to solicit specific 
feedback with regard to wording of questions, potential social desirability in responding, and 
ease of measure completion. Revisions were made in response to their feedback, leading to 
the third version (3.0) of the ACBQ which was used in this study. Because this is the initial 
study using the ACBQ, no psychometric properties can be reported.    
Asthma Management Self-Efficacy (AMSE; Bursch, Schwankovsky, Gilbert, & 
Zeiger, 1999). The AMSE (see Appendix B) is a 13 item measure that uses a 6-point Likert 
scale to gauge parents’ beliefs about their abilities to prevent asthma attacks (e.g., correctly 
administer medications, get child to doctor’s appointment) and manage asthma attacks (e.g., 
control symptoms, decide when to go to the emergency room).  The scale has demonstrated 
good internal consistency (α = .87) and construct validity.  Higher total score and subscale 
scores suggest greater perceived self-efficacy. 
Functional Severity Index (FSI; Fritz, McQuaid, Spirito, & Klein, 1996). The FSI (see 
Appendix C) is a 13-item, parent-report measure of children’s asthma symptoms and 
functional impairment (e.g., nighttime awakening, school absences). More specifically, the 
first six items of the scale assesses the frequency of episodes, frequency of symptoms 
between episodes, intensity of impairment during an episode, and intensity of impairment 
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between episodes, and the remainder of the scale assesses health care utilization and extreme 
asthma events. The FSI score was calculated by computing a mean for the first six items 
(Rosier, Bishop, Nolan, Robertson, Carlin, & Phelan, 1994). Higher FSI scores suggest 
increased symptoms and impairment. Internal consistency for the first six items of the current 
sample was calculated at alpha = .86. Previous studies have reported full scale reliability 
estimates around alpha = .80 (e.g., McQuaid et al., 2003). 
Patient Information Form (PIF). The PIF (see Appendix D) was designed specifically 
for this study to gather demographic and medical information about the child and his or her 
family. These data were used to describe the participant sample. 
Procedure 
 During the clinic appointment, a research assistant approached eligible participants, 
explained the purpose of the study, and offered them the opportunity to participate. Written 
informed consent, in accordance with hospital policy, was obtained prior to enrollment.  
Instructions for each questionnaire were explained in detail and caregivers completed the 
questionnaires independently unless they expressed a need for further clarification and/or 
reading assistance. The researcher also emphasized the confidential nature of the parent’s 
response and indicated that most families do not follow their regimen perfectly in an effort to 
reduce social desirability in responding. Parents completed the questionnaires in random 
order. Once parents completed the forms, they were compensated for their time with a $5 gift 
certificate.  
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Results 
Participants 
 One hundred and thirty five primary caregivers of children (1-17 years old; M = 7.86; 
SD = 4.15) with a diagnosis of asthma (average time since diagnosis = 5.24 years; SD = 
3.62) participated in the study during a regularly scheduled visit to an allergy and asthma 
clinic.  Approximately 62% of the children were male, with 56.4% identifying as Caucasian, 
30.8% as African-American, 6.8% as Hispanic American, 4.5% as Other Ethnicity, and 1.5% 
as Asian American. Most children had a diagnosis of mild or moderate persistent asthma 
(34.2% and 40.5%, respectively).   
 Caregivers ranged from 19 to 63 years of age (M = 35.46; SD = 7.62) with 85.7% of 
caregivers identifying themselves as mothers, 10.5% as fathers, and 3.8% as other (e.g., 
grandparent). Approximately half of the sample came from families with both biological 
parents living in the home, 26.5% from single parent homes, 12.9% from blended families 
(e.g., step-parent), and 6.8% reported other family structures (i.e., living with a grandparent). 
Median education level for mothers and fathers was vocational training and/or some college 
education, and the average annual income was between 30,000 and 39,999 dollars indicating 
that these families were in the lower to middle socioeconomic range. 
Preliminary Statistical Analyses 
For the first section of the ACBQ, item responses were collapsed into “increase 
medication” (increase dose, increase schedule), “decrease medication” (decrease dose, 
decrease schedule, stop medication altogether), or “no change” for each class of medication.  
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Although factor analysis would be the preferred method for deriving summary variables for 
the second section of the ACBQ (i.e., items tapping motivational factors for increasing or 
decreasing medications), sample size was not sufficient to produce a reliable factor structure. 
Consequently, a combination of expert ratings, item-to-total correlation analyses, and clinical 
judgment was employed to create summary variables for those 38 items. Specifically, two 
steps were taken. First, experts were provided with a complete list of items and a set of 
categories (see Table 1) in which to place each item, with the possibility of writing in their 
own category as well. These summary categories were created by reviewing research on the 
risk factors for and barriers to adherence (e.g., Bauman, 2000).  
Table 1:  Expert Category Definitions 
Category Description 
Anxiety Medications were increased to reduce anxiety. 
Symptom Control Medications were increased to prevent or control asthma exacerbations. 
Quality of Life (QoL) Medications were increased to improve the child’s quality of life (e.g., daily 
functioning). 
Perceived Need Medications were decreased because the family did not perceive a need for 
the medications prescribed or had a desire to determine whether or not there 
was a true physical need for the medication. 
Treatment Burden Medications were decreased because the family wanted to reduce the burden 
that the treatment imposed. 
Side Effects Medications were decreased to reduce or avoid medication side effects. 
Financial Concerns Medications were decreased due to financial concerns or desires. 
Mistrust Medications were decreased because the family mistrusted the prescribed 
medications. 
Child Medications were decreased in accordance with child preferences or 
because of child opposition. 
 
Expert raters consisted of a total of seven healthcare professionals (i.e., asthma 
educator, allergist, pediatric psychologist) from different regions of the U.S. An item was 
retained if at least 75% of the raters agreed on its category placement (DeVellis, 2003; 
Logan, Zelikovsky, Labay, & Spergel, 2003; see Tables 2-3 for deleted items).  
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Second, item-to-total correlations were conducted for each item retained by the expert 
ratings. Specifically, these correlations were assessed within each cluster of items rated as 
belonging to a particular category with more than one item. Items with a negative item-to-
total correlation were examined and deleted from the measure if it was determined that they 
were written in a relatively unclear manner (see Table 4). 
 
Thus, the following items were retained to create the ACBQ categories that were used in the 
primary analyses (see Tables 5-6). 
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Primary Analyses  
Aim 1:  The first aim of this study was to use the ACBQ to report descriptive data 
regarding the types of changes parents make to their children’s medications and what 
motivates those changes. Frequency analyses determined that 80.5% of the parents in this 
sample reported intentionally altering their child’s medications. More specifically, parents 
most often reported making changes to their child’s rescue medications such that 21.3% of 
the sample reported increasing their child’s rescue medications and 69% reported decreasing 
them. It was also more common for parents to decrease any type of their child’s medications 
(79.4%) than to increase any medication (25.6%). Thus, the descriptive data mirror previous 
research (e.g., Greaves et al., 2005) by suggesting that the majority of families are 
volitionally non-adherent. 
In addition to describing the types of changes parents of children with asthma make, 
it was further hypothesized that parents would be more likely to report increasing rescue 
medications and decreasing controller medications than the reverse. Considering the majority 
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of families reported decreasing medications regardless of the type, this hypothesis was not 
supported. It is possible that this finding contradicts previous research (e.g., Graves et al., in 
press; Modi & Quittner, 2006) because parents who are volitionally non-adherent may feel 
that daily medicines and short term medications, which still need to be on hand to be 
administered at times of need, pose comparable treatment barriers. 
Another descriptive hypothesis in this study speculated that parents would most often 
endorse motivating factors that improve their child’s quality of life and alleviate symptom 
exacerbations when increasing their child’s medications. According to frequency analyses 
conducted on the expert category variables, 85.7% of parents who increased their child’s 
medications endorsed symptom exacerbation as a motivating factor. Furthermore, 73.7% 
endorsed quality of life issues and 25.9% endorsed a desire to reduce anxiety.  Thus, the 
hypothesis regarding motivating factors for increasing medications was supported.  
It was also hypothesized that parents would endorse a desire to reduce treatment 
burden, evaluate the child’s need for medications, and decrease side effects as the most 
prevalent reasons for decreasing their child’s medications. In accordance with this 
hypothesis, the two most commonly reported reasons for decreasing medications were 
evaluating the child’s need for medications (59.2%) and attempting to reduce treatment 
burden (42.3%). However, the third most common motivating factor for decreasing 
medications was that the child expressed a preference for and/or opposition to aspects of the 
medication regimen (36.5%). Consequently, these results suggest that for both increasing and 
decreasing medications, parents are considering not only the child’s symptoms, but also how 
the medical regimen affects the child and the family as a whole.  
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Aim 2:  The second aim of this study was to examine whether parents who report 
volitional non-adherence significantly differ with regard to perceived self-efficacy in asthma 
prevention and management when compared to those parents who report adhering to their 
child’s regimen.  Three analyses of covariance (ANCOVA) were conducted with adherent 
versus volitionally non-adherent entered as the independent variable, the AMSE subscale 
scores and total score entered as the dependent variables (each in a separate ANCOVA), and 
time since diagnosis entered as a covariate. Results suggested that neither attack prevention 
(F 2,109 = .299, ns), attack management (F 2,109 = .630, ns), nor overall perceived asthma self-
efficacy (F 2,109 = 1.461, ns) discriminated between those parents who chose to alter their 
child’s prescribed medications and those who did not.  
Aim 3:  An independent samples t-test was used to determine whether parents 
reporting non-adherence and those reporting adherence differed significantly with regard to 
their child’s functional severity.  Results of this analysis were not significant (t 123 = -.247, 
ns), suggesting that the hypothesis that the two groups of parents would not differ 
significantly was supported.  
Discussion 
 The primary purpose of this study was to examine the presence of and motivating 
factors for volitional non-adherence in parents of children with asthma. According to the 
results, most of the parents in this sample reported intentionally changing their child’s 
medications. In fact, approximately 80% of parents reported decreasing their child’s 
medications. These findings add to the previous literature on non-adherence to asthma 
medication regimens by underscoring the high prevalence of non-adherence. In fact, these 
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self-reported rates of non-adherence are even higher than those reported by researchers who 
have not distinguished between volitional and inadvertent non-adherence (e.g., Cochrane et 
al., 2000; McQuaid et al., 2003). It is possible that focusing on volitional rather than 
inadvertent non-adherence may be perceived as less judgmental by patients, and normalizing 
non-adherence during the data collection process may have led to fewer demand 
characteristics. Yet, rates of volitional non-adherence in the current study are also somewhat 
higher than those found by Greaves et al. (2005).Thus, differences in measurement 
specificity may have also played a role in the discrepancy between current results and those 
from past research. For instance, Greaves and colleagues asked generalized questions about 
patterns of asthma medication use (e.g., do you take your medication regularly but less than 
recommended) and focused solely on controller medications.  In contrast, the first section of 
ACBQ details various ways (e.g., increase dose, increase frequency) in which a parent can 
alter each type of their child’s prescribed medicine which might in turn spark their memory 
for changes they may have otherwise not considered. Despite differing rates of non-
adherence, this study augments the existing literature by suggesting that non-adherence is 
more than simply forgetting to take medications or not understanding the medical regimen. 
Instead, the findings imply that many parents are in fact making reasoned decisions to change 
their child’s asthma medications and may even be deciding to face the possible risks 
associated with non-adherence because the benefits of non-adherence are perceived to be 
greater. 
 The reasons why parents are choosing to be volitionally non-adherent seem to center 
around the impact of the child’s asthma symptoms on the child and family’s life. For 
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instance, parents reported that controlling symptom exacerbations and improving quality of 
life were the most common reasons for increasing their child’s medications, and that 
evaluating the actual need for asthma medications, reducing treatment burden, and 
acquiescing to child preferences were the most common reasons for decreasing medications. 
It is not surprising that these factors were the most frequently endorsed reasons for engaging 
in volitional non-adherence as they have often been endorsed as barriers to treatment in 
general. For instance, Modi and Quittner (2006) found that the most commonly reported 
barriers to asthma treatment included time management issues, side effects, and oppositional 
child behaviors. These findings also lend support to Bauman’s (2000) theory that factors 
specifically related to volitional, and not inadvertent, non-adherence would include the 
burden of the medical regimen, skepticism about the efficacy of treatment, and issues 
regarding medication side effects.  
This correspondence between motivating factors for volitional non-adherence and 
barriers to adherence implies a need for better provider-patient communication. For instance, 
Noble (1998) recommended that health providers preface conversations with the expectation 
of non-adherence so that parents do not feel judged and are more open to discussion. Such 
open communication could in turn allow providers to better incorporate the family’s concerns 
about barriers to treatment and address the factors that motivate them to be non-adherent.  
Simple changes such as altering the medication regimen to prescribe controllers once a day 
instead of twice a day may sufficiently address parents’ concerns about treatment burden and 
negate poor adherence outcomes. Furthermore, if providers gain an understanding of what 
idiosyncratic factors motivate families not to follow their child’s asthma regimen, they may 
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also be able to determine whether or not a family’s specific reasons for non-adherence are 
appropriate (Greaves et al., 2005). For instance, skepticism about the efficacy of the 
medications or belief that a child has outgrown the illness may be inaccurate and indicate a 
need for educational interventions.  Indeed, if healthcare providers do not regularly address 
such motivating factors in their appointments with families, family adherence will likely not 
be optimized. 
 While these results have provided some initial insight into the occurrence of 
volitional non-adherence, the exploratory findings regarding the role of parents’ perceived 
asthma self-efficacy in adherence were contrary to what was predicted. It is possible that 
parents who are adherent report high perceived asthma self-efficacy because they are 
following their providers’ recommendations and experiencing optimal health outcomes. 
Similarly, parents who are endorsing volitional non-adherence may report comparable levels 
of self-efficacy because other variables that may play a role in the relationship between non-
adherence and self-efficacy are also promoting good health outcomes. For instance, patient 
knowledge and changing expectations of patient roles may factor into parents’ decisions not 
to adhere (Korsch & Marcy, 2000). Indeed, the increasing availability of medical resources 
(e.g., via the internet) gives parents greater access to answers about questions they might 
have about how to change their child’s regimens on their own. Furthermore, asthma action 
plans empower parents to engage in at least some decision-making by promoting symptom-
based interventions. Thus, while parents who are adherent may have children with good 
symptom control, parents who are non-adherent may also have children who experience good 
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symptom control because they are using available resources to make educated decisions 
about how to change their child’s asthma regimen.  
 As findings regarding self-efficacy suggest, parents who endorse volitional non-
adherence and parents who report being adherent to their child’s asthma regimen may not be 
so different.  And in fact, the final aim of the study suggested that these two types of parents 
reported similar levels of asthma symptoms and functional impairment in their children. This 
may imply that parents who are volitionally non-adherent are still meeting their child’s basic 
needs by administering enough medication to sustain good health outcomes. This lends 
support to the idea that there may in fact be an adequate level of adherence (Deaton, 1985) 
and that adjusting regimens to determine that adequate level of use (e.g., prescribing 
intermittent instead of daily controller medications as suggested by Boushey et al., 2005) 
should be considered in the future. In fact, this result is promising in that it suggests that 
there may be more flexibility than previously thought for provider’s to address treatment 
barriers because parents are already demonstrating that making some changes to the asthma 
medication regimen is not necessarily maladaptive. Thus, parents could be educating 
providers on various ways to prescribe medications by sharing their personal expertise with 
their providers, and providers could educate parents on which changes have the greatest 
research support. 
It should be noted, however, that this study utilized only parent-report. As a result, it 
is unclear if a difference in health outcomes would occur between volitionally non-adherent 
parents and adherent parents if the variables were derived from some other source (e.g., 
health care utilization data from chart review). Despite the argument that parents who are 
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volitionally non-adherent and parents who are adherent may be more similar than anticipated; 
other factors may still play a role in distinguishing families who engage in volitional non-
adherence. Thus, future researchers should consider what other psychological, 
environmental, and medical factors (e.g., quality of life, access to educational resources) may 
characterize volitionally non-adherent families.   
Limitations  
 This study had a few limitations.  First, because the overall project continues to gather 
more participants, the sample size for this preliminary analysis was insufficient to perform 
the appropriate psychometric analyses (i.e., factor analysis for a portion of its items) on the 
ACBQ and the results are primarily descriptive in nature. Thus, it is important to remain 
cautious when interpreting the results (particularly those from the summary variables for 
motivating factors) and potential implications of this study. It should be noted, however, that 
the sample was large enough to provide sufficient power for the statistical analyses 
conducted and reported here. A second limitation is that the representativeness of the sample 
may have been compromised because the sample was recruited from specialty asthma clinics 
which often see children with more poorly controlled asthma than primary care physicians. In 
other words, these families may be more non-adherent than the average asthma population, 
which could be reflected in the elevated rates of non-adherence. Third, the ACBQ is still 
under development. For instance, this version of the ACBQ only gave parents the option to 
identify their behaviors as adherent or volitionally non-adherent. Therefore, because families 
who engaged in inadvertent non-adherence could be included in either of these groups, the 
two groups of parents may be more similar than anticipated making it difficult to detect 
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significant differences between them. In addition to adding the option to indicate inadvertent 
non-adherence to future versions of the measure, the format continues to be reconsidered as 
many families have expressed difficulties completing the measure independently. 
Consequently, a more streamlined version of the questionnaire or a semi-structured interview 
format may be more helpful. Changes that have already been incorporated into the attached 
edition of the ACBQ (see Appendix A) include adding pictures to help families distinguish 
which types of medications are being asking about, adding arrows to indicate which 
questions adherent parents can skip, and deleting confusing items in the section that queried 
about methods of making changes to medications. Despite these changes, the question of 
specificity versus generality in item content remains. For instance, simply knowing that a 
parent decreased their child’s controller medication, and not that they decreased it by 
frequency instead of dose, may be sufficient.  
Future Directions and Implications 
 Despite these limitations, this study sets the groundwork for future research on 
adherence theories by beginning to characterize volitional non-adherence in a sample of 
parents of children with asthma.  As researchers’ understanding of this concept improves, 
examining the psychological and health outcomes associated with differing levels and types 
of volitional non-adherence would be beneficial.  For instance, determining whether there is 
a certain level at which non-adherence becomes maladaptive (Deaton, 1985), gaining greater 
insight into how to discriminate between inadvertent and volitional non-adherence (Bauman, 
2000), and improving health care professionals’ understanding of the health outcomes 
associated with increasing medications could inform clinical interventions. Interventions that 
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also encourage non-judgmental doctor-patient communication by taking into account 
patients’ views and expertise could lead to improved adherence to prescribed treatment 
regimens (Korsch & Marcy, 2000; Noble, 1998). Moreover, encouraging open provider-
patient discussions when volitional non-adherence is recognized may lead to improved 
adherence outcomes because specific barriers to treatment can be addressed. While there are 
many possible implications for future research and interventions, the immediate implication 
of this study is our understanding that many parents of children with asthma are not sitting 
passively and waiting to be told what to do to manage their child’s illness. Thus, instead of 
presuming that parents will conform to the providers’ recommendations, providers should 
take advantage of the personal expertise and advocacy that parents are demonstrating by 
querying and considering families’ views when creating treatment regimens.   
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Appendix A.  Asthma Care Behaviors Questionnaire (ACBQ) 
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